S. 77Senate113th Congress (2013-2015)In Committee

Prescription Drug and Health Improvement Act of 2013

Sponsored by Al  Franken Sen. Al Franken (D-MN)
Introduced January 23, 2013

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Finance.

January 23, 2013

View full timeline
SenateIntro Referral

Introduced in Senate

January 23, 2013

SenateIntro Referral

Read twice and referred to the Committee on Finance.

January 23, 2013

Floor Debate

1 member

What members said about S. 77 on the floor

1 Democrat
Alan S. Lowenthal
Rep. Alan S. LowenthalD-CA-47 · Nov 18, 2013

Mr. Speaker, the recent opening of the $340-million Gov. George Deukmejian Courthouse in Long Beach is the culmination of nearly a decade of work. Part of the Los Angeles County Superior Court…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued January 23, 2013

II

113th CONGRESS

1st Session

S. 77

IN THE SENATE OF THE UNITED STATES

January 23 (legislative day, January 3), 2013

Mr. Franken (for himself and Ms. Klobuchar) introduced the following bill; which was read twice and referred to the Committee on Finance

A BILL

To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate for lower prices for Medicare prescription drugs.

1.

Short title

This Act may be cited as the Prescription Drug and Health Improvement Act of 2013.

2.

Negotiating fair prices for medicare prescription drugs

(a)

Negotiating fair prices

(1)

In general

Section 1860D–11 of the Social Security Act (42 U.S.C. 1395w–111) is amended by striking subsection (i) (relating to noninterference) and by inserting the following:

(i)

Authority To negotiate prices with manufacturers

In order to ensure that beneficiaries enrolled under prescription drug plans and MA–PD plans pay the lowest possible price, the Secretary shall have authority similar to that of other Federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs, consistent with the requirements and in furtherance of the goals of providing quality care and containing costs under this part.

.

(2)

Effective date

The amendment made by paragraph (1) shall take effect on the date of the enactment of this Act.

(b)

Biannual reports to Congress

Not later than 1 year after the date of the enactment of this Act, and every 6 months thereafter, the Secretary of Health and Human Services shall submit to Congress a report on the negotiations conducted by the Secretary under section 1860D–11(i) of the Social Security Act (42 U.S.C. 1395w–111(i)), as amended by subsection (a), including a description of how such negotiations are achieving lower prices for covered part D drugs (as defined in section 1860D–2(e) of the Social Security Act (42 U.S.C. 1395w–102(e))) for Medicare beneficiaries.